Maxidex

Dexamethasone, the active ingredient in Maxidex, is a corticosteroid presented as a 0.1% w/v ophthalmic suspension for ocular use. It treats postoperative ocular inflammation, uveitis, allergic conjunctivitis, iritis, and keratitis in patients requiring anti‑inflammatory therapy.

GNH USA supplies Maxidex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable logistics for global healthcare providers. The product conforms to EU pharmacopeial standards and is manufactured under strict GMP conditions. It is distributed through a network of certified cold‑chain partners to maintain stability.

Maxidex (dexamethasone ophthalmic suspension) is employed to manage ocular inflammatory conditions.

- Post‑operative ocular inflammation: reduces swelling, pain and cellular infiltrate after eye surgery. - Uveitis: suppresses intra‑ocular inflammation to preserve visual function. - Allergic conjunctivitis: alleviates redness, itching and edema caused by allergic reactions. - Iritis: diminishes anterior chamber inflammation and associated discomfort. - Keratitis: controls corneal inflammation and promotes healing.

Ocular administration of dexamethasone may be associated with a range of adverse ocular and systemic reactions.

Common Side Effects: - Transient eye irritation or burning sensation - Temporary increase in intra‑ocular pressure - Blurred vision - Excessive tearing or discharge

Serious or Rare Side Effects: - Development of cataract with prolonged use - Secondary glaucoma leading to optic nerve damage - Severe hypersensitivity reaction including eyelid edema and conjunctival swelling

When prescribing Maxidex, clinicians should observe several safety considerations.

- Monitor intra‑ocular pressure: patients with glaucoma risk require regular pressure checks. - Avoid use in active viral eye infections: corticosteroids may worsen viral replication. - Do not wear contact lenses during treatment: remove lenses before each dose. - Limit duration of therapy: use only as directed to minimize risk of cataract formation. - Store at room temperature: keep bottle tightly closed, protect from light and moisture.

Dexamethasone eye drops can interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Concurrent use with other ocular corticosteroids: additive risk of intra‑ocular pressure elevation. - Combination with topical non‑steroidal anti‑inflammatory eye drops: may increase corneal melting risk.

Moderate Interactions (Monitor Closely): - Systemic corticosteroids: monitor for cumulative glucocorticoid effects. - Anticholinergic ophthalmic agents: may reduce drug absorption. - Beta‑blocker eye drops: observe for potential ocular hypertension.